In Vitro Suppression of the Lipogenic Pathway by the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz in 3T3 and Human Preadipocytes or Adipocytes
Open Access
- 1 April 2004
- journal article
- Published by Elsevier
- Vol. 279 (15), 15130-15141
- https://doi.org/10.1074/jbc.m312875200
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Differential effect of HIV protease inhibitors on adipogenesisAIDS, 2003
- Efavirenz‐Associated Severe HyperlipidemiaClinical Infectious Diseases, 2002
- HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the NucleusJournal of Biological Chemistry, 2001
- Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase InhibitorsClinical Pharmacokinetics, 2001
- Preliminary Experience of Adverse Drug Reactions, Tolerability, and Efficacy of a Once-Daily Regimen of Antiretroviral Combination TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV‐1) Suppression and Efavirenz Drug Concentrations in HIV‐1–Infected Patients Receiving Combination TherapyThe Journal of Infectious Diseases, 1999
- Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineAIDS, 1998
- Sterol Regulation of Fatty Acid Synthase PromoterJournal of Biological Chemistry, 1995
- Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipaseEndocrinology, 1994
- A Method for Isolation of Intact, Translationally Active Ribonucleic AcidDNA, 1983